Kitazato IPO Trading - Demand Was Strong
Kitazato (368A JP) manufactures and sells medical devices and products for fertility treatment. It raised around US$130m in its Japan IPO. In this...
327 Views
APAC Healthcare Weekly (June 15)- CSPC, Wuxi Bio, Samsung Bio, Daiichi Sankyo, SanBio, Cochlear
CSPC entered research collaboration with AstraZeneca. Wuxi Bio is constructing new plant in China. Samsung Bio signed new CDMO contract. Daiichi...
380 Views
Kitazato IPO - Isn’t Particularly Enticing Apart from the Dividend Yield
Kitazato (368A JP) manufactures and sells medical devices and products for fertility treatment. It aims to raise around US$130m in its Japan IPO.
390 Views
BIG Nippon Electric Glass (5214) Buyback, Possibly Offset by Cross-Holder Selling
Nippon Electric Glass is rebuilding this year, hopes to be better over the next 5yrs. They now target 8% ROE, 2% DOE, and expect to spend ¥50bn on...
497 Views
PHC Holdings IPO Lock-Up - Stock Might Be Cheap but It’s Stuck with a US$1bn Overhang
PHC Holding had raised US$645m in its Japan IPO in Oct 2021, after the deal was downsized and priced at the low-end. The lock-up on pre-IPO...
705 Views